TLIK.F TELES Informationstechnologien AG

Healthcare Communications Equipment Frankfurt Exchange
0.0010 EUR
Close of Nov 5, 2026
0.0005 0.5500
Market cap
EUR 6.23K
P/E
-
P/B
17.92x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is TLIK.F undervalued?

Graham number

The Graham number of TELES Informationstechnologien AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

TELES Informationstechnologien AG fundamental analysis

No fundamental analysis for TELES Informationstechnologien AG yet.

TELES Informationstechnologien AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About TELES Informationstechnologien AG

Arzneiwerk AG VIDA supplies pharmaceuticals for newly developed or rare medicines in Europe. It also provides medications for cancer, autoimmune deficiencies, and combination therapies of personalized medicine. In addition, the company is involved in operating pharmacy data center that focuses on health data analysis. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is…

Full company profile